Barry E. Greene, President and CEO at Sage Therapeutics, Inc. (SAGE), bought 8,800 shares at $56.32 ($496K) on 2021-06-16, disclosed to the SEC on 2021-06-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| ALNY | SELL | 2020-09-11 | $11.0M | — | Filing → |
| ALNY | SELL | 2020-07-09 | $7.1M | — | Filing → |
| ALNY | SELL | 2020-05-07 | $6.7M | — | Filing → |